Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials.

Shet P, Ghosh P, Varshney K, Sawdagar S

Open source

DOI
10.1177/15330338261452884
Published
2026 Jan-Dec
Container
Technology in cancer research & treatment
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/15330338261452884,
  title = {Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials.},
  author = {Shet P and Ghosh P and Varshney K and Sawdagar S},
  year = {2026},
  journal = {Technology in cancer research \& treatment},
  doi = {10.1177/15330338261452884},
  url = {https://doi.org/10.1177/15330338261452884}
}

RIS

TY  - JOUR
TI  - Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials.
AU  - Shet P
AU  - Ghosh P
AU  - Varshney K
AU  - Sawdagar S
PY  - 2026
JO  - Technology in cancer research & treatment
DO  - 10.1177/15330338261452884
UR  - https://doi.org/10.1177/15330338261452884
ER  - 

APA

P, S., P, G., K, V., & S, S. (2026). Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials.. Technology in cancer research & treatment. https://doi.org/10.1177/15330338261452884

Source records